Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Iodine | HCID 807 | — |
| Reactant | HCID 178526903 | HCID 178526903 | — |
| Product | HCID 178506566 | HCID 178506566 | — |
Reaction Steps
In step 1 of Scheme A, nitroindazole compound a is treated with iodine or iodine equivalent to form 3-iodo indazole compound b. The amine functionality at the 1-position may be protected (not shown) prior to carrying out this step, and then subsequently deprotected. In step 2 the iodoindazole b is reacted with aryl boronic acid c in the presence of suitable palladium catalyst to afford 3-aryl indazole d. Aryl boronic acid c may in certain embodiments be replaced with a corresponding heteroaryl boronic acid. In step 3 the nitro group on indazole compound d is reduced to yield amino-substituted indazole e. Indazole e in step 4 is then treated with arylsulfonyl chloride f to form the sulfonamide compound g, Compound g is a compound of formula Ia in accordance with the invention.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07517901B2 |
|---|
| Source dataset | uspto-grants-2009_04 |
|---|
| ORD ID | ord-765a451d8b9141bba8606b829738ba36 |
|---|
| Source note | uspto-grants-2009_04 |
|---|